Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Total 13F shares
-
44,933,850
-
Share change
-
+342,529
-
Total reported value
-
$685,195,121
-
Put/Call ratio
-
33%
-
Price per share
-
$15.25
-
Number of holders
-
209
-
Value change
-
+$7,308,210
-
Number of buys
-
111
-
Number of sells
-
105
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q1 2016
As of 31 Mar 2016,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) was held by
209 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,933,850 shares.
The largest 10 holders included
BlackRock Fund Advisors, Ranger Investment Management, L.P., GLENMEDE TRUST CO NA, VANGUARD GROUP INC, Apex Capital Management, ACADIAN ASSET MANAGEMENT LLC, FMR LLC, Bank of New York Mellon Corp, Invesco Ltd., and Neumeier Poma Investment Counsel LLC.
This page lists
209
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.